Listed

Solid Biosciences Inc.

SLDBNasdaqCIK 1707502HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$57.4m, Q2 FY2026
Net income−$54.8m, Q2 FY2026
Solid Biosciences Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$m16.7Research and development, Q3 FY2023, three months to 2023-09-30$16.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-06, accession 0000950170-24-122247.Report this figure15.5Research and development, Q4 FY2023, three months to 2023-12-31$15.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-06, accession 0000950170-25-034644. Derived: 12-month figure less the 9-month figure.Report this figure18.9Research and development, Q1 FY2024, three months to 2024-03-31$18.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-15, accession 0000950170-25-072560.Report this figure19.5Research and development, Q2 FY2024, three months to 2024-06-30$19.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-12, accession 0000950170-25-107279.Report this figure27.3Research and development, Q3 FY2024, three months to 2024-09-30$27.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-03, accession 0001193125-25-262818.Report this figure30.8Research and development, Q4 FY2024, three months to 2024-12-31$30.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-19, accession 0001193125-26-115928. Derived: 12-month figure less the 9-month figure.Report this figure30.9Research and development, Q1 FY2025, three months to 2025-03-31$30.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001193125-26-219337.Report this figure32.4Research and development, Q2 FY2025, three months to 2025-06-30$32.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-337935.Report this figure38.9Research and development, Q3 FY2025, three months to 2025-09-30$38.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-03, accession 0001193125-25-262818.Report this figure38.1Research and development, Q4 FY2025, three months to 2025-12-31$38.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-19, accession 0001193125-26-115928. Derived: 12-month figure less the 9-month figure.Report this figure46.1Research and development, Q1 FY2026, three months to 2026-03-31$46.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001193125-26-219337.Report this figure44.3Research and development, Q2 FY2026, three months to 2026-06-30$44.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-337935.Report this figure
Operating income$m(23.1)Operating income, Q3 FY2023, three months to 2023-09-30−$23.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-06, accession 0000950170-24-122247.Report this figure(22.3)Operating income, Q4 FY2023, three months to 2023-12-31−$22.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-06, accession 0000950170-25-034644. Derived: 12-month figure less the 9-month figure.Report this figure(26.9)Operating income, Q1 FY2024, three months to 2024-03-31−$26.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-15, accession 0000950170-25-072560.Report this figure(27.8)Operating income, Q2 FY2024, three months to 2024-06-30−$27.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-12, accession 0000950170-25-107279.Report this figure(35.2)Operating income, Q3 FY2024, three months to 2024-09-30−$35.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-03, accession 0001193125-25-262818.Report this figure(39.9)Operating income, Q4 FY2024, three months to 2024-12-31−$39.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-19, accession 0001193125-26-115928. Derived: 12-month figure less the 9-month figure.Report this figure(40.1)Operating income, Q1 FY2025, three months to 2025-03-31−$40.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001193125-26-219337.Report this figure(41.7)Operating income, Q2 FY2025, three months to 2025-06-30−$41.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-337935.Report this figure(48.1)Operating income, Q3 FY2025, three months to 2025-09-30−$48.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-03, accession 0001193125-25-262818.Report this figure(49.4)Operating income, Q4 FY2025, three months to 2025-12-31−$49.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-19, accession 0001193125-26-115928. Derived: 12-month figure less the 9-month figure.Report this figure(57.3)Operating income, Q1 FY2026, three months to 2026-03-31−$57.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001193125-26-219337.Report this figure(57.4)Operating income, Q2 FY2026, three months to 2026-06-30−$57.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-337935.Report this figure
Interest expense$m0.1Interest expense, Q3 FY2023, three months to 2023-09-30$106.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2024-11-06, accession 0000950170-24-122247.Report this figure0.1Interest expense, Q4 FY2023, three months to 2023-12-31$101.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2025-03-06, accession 0000950170-25-034644. Derived: 12-month figure less the 9-month figure.Report this figure0.1Interest expense, Q1 FY2024, three months to 2024-03-31$95.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-15, accession 0000950170-24-060034.Report this figure0.1Interest expense, Q2 FY2024, three months to 2024-06-30$88.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-08-13, accession 0000950170-24-096130.Report this figure0.1Interest expense, Q3 FY2024, three months to 2024-09-30$82.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-03, accession 0001193125-25-262818.Report this figure0.1Interest expense, Q4 FY2024, three months to 2024-12-31$75.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-19, accession 0001193125-26-115928. Derived: 12-month figure less the 9-month figure.Report this figure0.1Interest expense, Q1 FY2025, three months to 2025-03-31$68.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-12, accession 0001193125-26-219337.Report this figure0.1Interest expense, Q2 FY2025, three months to 2025-06-30$60.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-06, accession 0001193125-26-337935.Report this figure(0.3)Interest expense, Q3 FY2025, three months to 2025-09-30−$336.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-03, accession 0001193125-25-262818.Report this figure0.0Interest expense, Q4 FY2025, three months to 2025-12-31$5.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-19, accession 0001193125-26-115928. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported
Income tax$m0.0Income tax, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2023-11-08, accession 0000950170-23-061096.Report this figure0.0Income tax, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-06, accession 0000950170-25-034644. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-05-15, accession 0000950170-24-060034.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-08-13, accession 0000950170-24-096130.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Net income$m(21.0)Net income, Q3 FY2023, three months to 2023-09-30−$21.0m. XBRL concept us-gaap:ProfitLoss. 10-Q filed 2024-11-06, accession 0000950170-24-122247.Report this figure(20.3)Net income, Q4 FY2023, three months to 2023-12-31−$20.3m. XBRL concept us-gaap:ProfitLoss. 10-K filed 2025-03-06, accession 0000950170-25-034644. Derived: 12-month figure less the 9-month figure.Report this figure(24.3)Net income, Q1 FY2024, three months to 2024-03-31−$24.3m. XBRL concept us-gaap:ProfitLoss. 10-Q filed 2025-11-03, accession 0001193125-25-262818.Report this figure(25.1)Net income, Q2 FY2024, three months to 2024-06-30−$25.1m. XBRL concept us-gaap:ProfitLoss. 10-Q filed 2025-11-03, accession 0001193125-25-262818.Report this figure(32.7)Net income, Q3 FY2024, three months to 2024-09-30−$32.7m. XBRL concept us-gaap:ProfitLoss. 10-Q filed 2025-11-03, accession 0001193125-25-262818.Report this figure(42.6)Net income, Q4 FY2024, three months to 2024-12-31−$42.6m. XBRL concept us-gaap:ProfitLoss. 10-K filed 2026-03-19, accession 0001193125-26-115928. Derived: 12-month figure less the 9-month figure.Report this figure(39.3)Net income, Q1 FY2025, three months to 2025-03-31−$39.3m. XBRL concept us-gaap:ProfitLoss. 10-Q filed 2026-08-06, accession 0001193125-26-337935.Report this figure(39.5)Net income, Q2 FY2025, three months to 2025-06-30−$39.5m. XBRL concept us-gaap:ProfitLoss. 10-Q filed 2026-08-06, accession 0001193125-26-337935.Report this figure(45.8)Net income, Q3 FY2025, three months to 2025-09-30−$45.8m. XBRL concept us-gaap:ProfitLoss. 10-Q filed 2025-11-03, accession 0001193125-25-262818.Report this figure(49.8)Net income, Q4 FY2025, three months to 2025-12-31−$49.8m. XBRL concept us-gaap:ProfitLoss. 10-K filed 2026-03-19, accession 0001193125-26-115928. Derived: 12-month figure less the 9-month figure.Report this figure(56.7)Net income, Q1 FY2026, three months to 2026-03-31−$56.7m. XBRL concept us-gaap:ProfitLoss. 10-Q filed 2026-08-06, accession 0001193125-26-337935.Report this figure(54.8)Net income, Q2 FY2026, three months to 2026-06-30−$54.8m. XBRL concept us-gaap:ProfitLoss. 10-Q filed 2026-08-06, accession 0001193125-26-337935.Report this figure
Diluted EPS$ per share(1.05)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$1.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-06, accession 0000950170-24-122247.Report this figurenot reported(0.64)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.64 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-15, accession 0000950170-25-072560.Report this figure(0.61)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.61 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-12, accession 0000950170-25-107279.Report this figure(0.79)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.79 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-03, accession 0001193125-25-262818.Report this figurenot reported(0.59)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.59 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001193125-26-219337.Report this figure(0.42)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.42 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001193125-26-337935.Report this figure(0.48)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.48 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-03, accession 0001193125-25-262818.Report this figurenot reported(0.52)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.52 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001193125-26-219337.Report this figure(0.38)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.38 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001193125-26-337935.Report this figure
Basic EPS$ per share(1.05)Basic EPS, Q3 FY2023, three months to 2023-09-30−$1.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-06, accession 0000950170-24-122247.Report this figurenot reported(0.64)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.64 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-15, accession 0000950170-25-072560.Report this figure(0.61)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.61 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-12, accession 0000950170-25-107279.Report this figure(0.79)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.79 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-03, accession 0001193125-25-262818.Report this figurenot reported(0.59)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.59 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001193125-26-219337.Report this figure(0.42)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.42 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001193125-26-337935.Report this figure(0.48)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.48 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-03, accession 0001193125-25-262818.Report this figurenot reported(0.52)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.52 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001193125-26-219337.Report this figure(0.38)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.38 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001193125-26-337935.Report this figure

Balance sheet

Cash and equivalents$159.4m, Q2 FY2026
Shareholders' equity$374.1m, Q2 FY2026
Solid Biosciences Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m49.0Cash and equivalents, Q3 FY2023, at 2023-09-30$49.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-06, accession 0000950170-24-122247.Report this figure74.0Cash and equivalents, FY2023, at 2023-12-31$74.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-06, accession 0000950170-25-034644.Report this figure118Cash and equivalents, Q1 FY2024, at 2024-03-31$117.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-15, accession 0000950170-25-072560.Report this figure95.9Cash and equivalents, Q2 FY2024, at 2024-06-30$95.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-12, accession 0000950170-25-107279.Report this figure64.4Cash and equivalents, Q3 FY2024, at 2024-09-30$64.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-03, accession 0001193125-25-262818.Report this figure80.2Cash and equivalents, FY2024, at 2024-12-31$80.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-19, accession 0001193125-26-115928.Report this figure211Cash and equivalents, Q1 FY2025, at 2025-03-31$210.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-12, accession 0001193125-26-219337.Report this figure139Cash and equivalents, Q2 FY2025, at 2025-06-30$138.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-337935.Report this figure61.4Cash and equivalents, Q3 FY2025, at 2025-09-30$61.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-03, accession 0001193125-25-262818.Report this figure59.9Cash and equivalents, FY2025, at 2025-12-31$59.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-337935.Report this figure297Cash and equivalents, Q1 FY2026, at 2026-03-31$297.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-12, accession 0001193125-26-219337.Report this figure159Cash and equivalents, Q2 FY2026, at 2026-06-30$159.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-337935.Report this figure
Current assets$m148Current assets, Q3 FY2023, at 2023-09-30$148.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-08, accession 0000950170-23-061096.Report this figure130Current assets, FY2023, at 2023-12-31$129.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-06, accession 0000950170-25-034644.Report this figure214Current assets, Q1 FY2024, at 2024-03-31$214.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-15, accession 0000950170-24-060034.Report this figure198Current assets, Q2 FY2024, at 2024-06-30$197.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-13, accession 0000950170-24-096130.Report this figure179Current assets, Q3 FY2024, at 2024-09-30$179.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-06, accession 0000950170-24-122247.Report this figure157Current assets, FY2024, at 2024-12-31$157.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-19, accession 0001193125-26-115928.Report this figure313Current assets, Q1 FY2025, at 2025-03-31$313.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-15, accession 0000950170-25-072560.Report this figure279Current assets, Q2 FY2025, at 2025-06-30$278.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-12, accession 0000950170-25-107279.Report this figure245Current assets, Q3 FY2025, at 2025-09-30$244.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-03, accession 0001193125-25-262818.Report this figure205Current assets, FY2025, at 2025-12-31$205.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-337935.Report this figure397Current assets, Q1 FY2026, at 2026-03-31$396.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-12, accession 0001193125-26-219337.Report this figure395Current assets, Q2 FY2026, at 2026-06-30$395.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-337935.Report this figure
Total assets$m185Total assets, Q3 FY2023, at 2023-09-30$184.7m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-08, accession 0000950170-23-061096.Report this figure165Total assets, FY2023, at 2023-12-31$164.9m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-06, accession 0000950170-25-034644.Report this figure249Total assets, Q1 FY2024, at 2024-03-31$248.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-15, accession 0000950170-24-060034.Report this figure231Total assets, Q2 FY2024, at 2024-06-30$231.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-13, accession 0000950170-24-096130.Report this figure212Total assets, Q3 FY2024, at 2024-09-30$211.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-06, accession 0000950170-24-122247.Report this figure189Total assets, FY2024, at 2024-12-31$188.7m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-19, accession 0001193125-26-115928.Report this figure344Total assets, Q1 FY2025, at 2025-03-31$343.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-15, accession 0000950170-25-072560.Report this figure308Total assets, Q2 FY2025, at 2025-06-30$308.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-12, accession 0000950170-25-107279.Report this figure274Total assets, Q3 FY2025, at 2025-09-30$273.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-03, accession 0001193125-25-262818.Report this figure233Total assets, FY2025, at 2025-12-31$232.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-337935.Report this figure423Total assets, Q1 FY2026, at 2026-03-31$422.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-12, accession 0001193125-26-219337.Report this figure421Total assets, Q2 FY2026, at 2026-06-30$420.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-337935.Report this figure
Current liabilities$m15.8Current liabilities, Q3 FY2023, at 2023-09-30$15.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-08, accession 0000950170-23-061096.Report this figure14.5Current liabilities, FY2023, at 2023-12-31$14.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-06, accession 0000950170-25-034644.Report this figure14.3Current liabilities, Q1 FY2024, at 2024-03-31$14.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-15, accession 0000950170-24-060034.Report this figure14.7Current liabilities, Q2 FY2024, at 2024-06-30$14.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-13, accession 0000950170-24-096130.Report this figure22.9Current liabilities, Q3 FY2024, at 2024-09-30$22.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-06, accession 0000950170-24-122247.Report this figure30.3Current liabilities, FY2024, at 2024-12-31$30.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-19, accession 0001193125-26-115928.Report this figure28.8Current liabilities, Q1 FY2025, at 2025-03-31$28.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-15, accession 0000950170-25-072560.Report this figure29.8Current liabilities, Q2 FY2025, at 2025-06-30$29.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-12, accession 0000950170-25-107279.Report this figure36.3Current liabilities, Q3 FY2025, at 2025-09-30$36.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-03, accession 0001193125-25-262818.Report this figure33.5Current liabilities, FY2025, at 2025-12-31$33.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-337935.Report this figure30.3Current liabilities, Q1 FY2026, at 2026-03-31$30.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-12, accession 0001193125-26-219337.Report this figure28.6Current liabilities, Q2 FY2026, at 2026-06-30$28.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-337935.Report this figure
Total liabilities$m40.4Total liabilities, Q3 FY2023, at 2023-09-30$40.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-08, accession 0000950170-23-061096.Report this figure38.5Total liabilities, FY2023, at 2023-12-31$38.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-06, accession 0000950170-25-034644.Report this figure38.0Total liabilities, Q1 FY2024, at 2024-03-31$38.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-15, accession 0000950170-24-060034.Report this figure37.7Total liabilities, Q2 FY2024, at 2024-06-30$37.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-13, accession 0000950170-24-096130.Report this figure44.8Total liabilities, Q3 FY2024, at 2024-09-30$44.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-06, accession 0000950170-24-122247.Report this figure51.4Total liabilities, FY2024, at 2024-12-31$51.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-19, accession 0001193125-26-115928.Report this figure49.4Total liabilities, Q1 FY2025, at 2025-03-31$49.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-15, accession 0000950170-25-072560.Report this figure50.0Total liabilities, Q2 FY2025, at 2025-06-30$50.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-12, accession 0000950170-25-107279.Report this figure56.0Total liabilities, Q3 FY2025, at 2025-09-30$56.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-03, accession 0001193125-25-262818.Report this figure52.5Total liabilities, FY2025, at 2025-12-31$52.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-337935.Report this figure48.8Total liabilities, Q1 FY2026, at 2026-03-31$48.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-12, accession 0001193125-26-219337.Report this figure46.5Total liabilities, Q2 FY2026, at 2026-06-30$46.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-337935.Report this figure
Shareholders' equity$m144Shareholders' equity, Q3 FY2023, at 2023-09-30$144.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-06, accession 0000950170-24-122247.Report this figure126Shareholders' equity, FY2023, at 2023-12-31$126.5m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-19, accession 0001193125-26-115928.Report this figure211Shareholders' equity, Q1 FY2024, at 2024-03-31$210.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-03, accession 0001193125-25-262818.Report this figure193Shareholders' equity, Q2 FY2024, at 2024-06-30$193.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-03, accession 0001193125-25-262818.Report this figure167Shareholders' equity, Q3 FY2024, at 2024-09-30$167.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-03, accession 0001193125-25-262818.Report this figure137Shareholders' equity, FY2024, at 2024-12-31$137.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-337935.Report this figure294Shareholders' equity, Q1 FY2025, at 2025-03-31$294.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-337935.Report this figure258Shareholders' equity, Q2 FY2025, at 2025-06-30$258.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-337935.Report this figure218Shareholders' equity, Q3 FY2025, at 2025-09-30$217.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-03, accession 0001193125-25-262818.Report this figure180Shareholders' equity, FY2025, at 2025-12-31$180.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-337935.Report this figure374Shareholders' equity, Q1 FY2026, at 2026-03-31$374.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-337935.Report this figure374Shareholders' equity, Q2 FY2026, at 2026-06-30$374.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-337935.Report this figure

Cash flow

Operating cash flow−$52.6m, Q2 FY2026
Capital expenditure$150.0k, Q2 FY2026
Solid Biosciences Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(17.9)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$17.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-06, accession 0000950170-24-122247. Derived: 9-month figure less the 6-month figure.Report this figure(20.8)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$20.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-06, accession 0000950170-25-034644. Derived: 12-month figure less the 9-month figure.Report this figure(25.2)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$25.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-15, accession 0000950170-25-072560.Report this figure(21.5)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$21.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-12, accession 0000950170-25-107279. Derived: 6-month figure less the 3-month figure.Report this figure(23.7)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$23.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-03, accession 0001193125-25-262818. Derived: 9-month figure less the 6-month figure.Report this figure(29.6)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$29.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-19, accession 0001193125-26-115928. Derived: 12-month figure less the 9-month figure.Report this figure(31.9)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$31.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001193125-26-219337.Report this figure(37.4)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$37.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-337935. Derived: 6-month figure less the 3-month figure.Report this figure(33.5)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$33.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-03, accession 0001193125-25-262818. Derived: 9-month figure less the 6-month figure.Report this figure(53.6)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$53.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-19, accession 0001193125-26-115928. Derived: 12-month figure less the 9-month figure.Report this figure(47.2)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$47.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001193125-26-219337.Report this figure(52.6)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$52.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-337935. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.4Capital expenditure, Q3 FY2023, three months to 2023-09-30$383.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-06, accession 0000950170-24-122247. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2023, three months to 2023-12-31$90.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-06, accession 0000950170-25-034644. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2024, three months to 2024-03-31$149.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-15, accession 0000950170-25-072560.Report this figure0.3Capital expenditure, Q2 FY2024, three months to 2024-06-30$286.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-12, accession 0000950170-25-107279. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$15.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-03, accession 0001193125-25-262818. Derived: 9-month figure less the 6-month figure.Report this figure0.2Capital expenditure, Q4 FY2024, three months to 2024-12-31$204.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-19, accession 0001193125-26-115928. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2025, three months to 2025-03-31$126.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-12, accession 0001193125-26-219337.Report this figure0.4Capital expenditure, Q2 FY2025, three months to 2025-06-30$377.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001193125-26-337935. Derived: 6-month figure less the 3-month figure.Report this figure0.1Capital expenditure, Q3 FY2025, three months to 2025-09-30$85.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-03, accession 0001193125-25-262818. Derived: 9-month figure less the 6-month figure.Report this figure0.6Capital expenditure, Q4 FY2025, three months to 2025-12-31$565.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-19, accession 0001193125-26-115928. Derived: 12-month figure less the 9-month figure.Report this figure0.2Capital expenditure, Q1 FY2026, three months to 2026-03-31$165.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-12, accession 0001193125-26-219337.Report this figure0.2Capital expenditure, Q2 FY2026, three months to 2026-06-30$150.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001193125-26-337935. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)143.69m, Q2 FY2026
Solid Biosciences Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares7.5Diluted shares (weighted), Q3 FY2022, three months to 2022-09-307,532,706 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-08, accession 0000950170-23-061096.Report this figure19.6Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3119,567,635 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-15, accession 0000950170-24-060034.Report this figure19.7Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3019,663,672 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-13, accession 0000950170-24-096130.Report this figure20.1Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3020,059,641 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-06, accession 0000950170-24-122247.Report this figure38.2Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3138,155,373 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-15, accession 0000950170-25-072560.Report this figure40.9Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3040,934,361 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-12, accession 0000950170-25-107279.Report this figure41.4Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3041,443,317 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-03, accession 0001193125-25-262818.Report this figure66.3Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3166,341,305 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001193125-26-219337.Report this figure94.1Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3094,140,286 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-337935.Report this figure94.4Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3094,417,746 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-03, accession 0001193125-25-262818.Report this figure110Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31109,811,461 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001193125-26-219337.Report this figure144Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30143,688,701 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-337935.Report this figure

Shares outstanding: 107.23mShares outstanding, period not labelled, at 2026-08-04107,225,238 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-337935.Report this figure at Aug 4, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. Listed shows no prices and gives no investment advice.